poisar

Stocks · News reference

Top 3 Financial Stocks That Could Sink Your Portfolio In Q3

Avi Kapoor

Three financial stocks are showing overbought signals, indicating short-term downside potential for momentum traders. RSI values and prices included.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

LIFEMKTXSAFT
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Not Specified

    Ethos Chief Underwriter Nichole Myers Shares Why So Many Americans Are Still Waiting to Get Life Insurance on YourUpdateTV

    Ethos research reveals that 72% of Americans wish they had purchased life insurance sooner, with 70% knowing they needed it before acting. The primary barrier is misconception about cost, though a healthy 30-year-old can obtain meaningful coverage for approximately $1 per day. Ethos has streamlined the application process to under 10 minutes online without medical exams, addressing historical delays of 6-8 weeks.

    LIFE
  4. Brodsky & Smith

    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

    Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and ensure fair value for shareholders. The investigations involve Personalis (acquired by Tempus AI for $16.25/share), Werewolf Therapeutics (acquired by Ambros Therapeutics), Beazer Homes (acquired by Dream Finders Homes for $33.50/share), and MarketAxess Holdings (acquired by Intercontinental Exchange for $167/share).

    PSNLHOWLBZHMKTX
  5. Zacks.Com

    Here's Why Investors Should Stay Neutral on MarketAxess Stock for Now

    MarketAxess (MKTX) is diversifying beyond U.S. credit with international expansion and new trading protocols, with non-U.S. credit revenues rising 9%. However, U.S. credit revenues declined 9%, and the stock carries an elevated forward P/E of 19.08X above industry average. The company maintains strong financials and consistent earnings beats, but faces risks from trading volume sensitivity and investment costs, warranting a neutral stance.

    MKTXMSMSPAMSPEMSPF